Effects of Pioglitazone on Endothelial Progenitor Cells in Type 2 Diabetic Patients With Vascular Complications - The SPLENDOR Study.
Phase of Trial: Phase IV
Latest Information Update: 27 Sep 2013
At a glance
- Drugs Pioglitazone (Primary) ; Glibenclamide; Metformin
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- Acronyms SPLENDOR
- 10 Jun 2017 Biomarkers information updated
- 27 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
- 24 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.